ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,109.76
0.19%
US Tech 100
17,259.60
0.11%
다우존스 지수
38,355.01
0.30%
Bitcoin
62,802.90
-0.31%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. TransCode Therapeutics Inc (RNAZ)

  7. TransCode Therapeutics Inc (RNAZ) 뉴스

RNAZ TransCode Therapeutics Inc

0.6059
0.056 (10.18%)
최종 업데이트: 03:33:30
15분 지연
기업명 주식 심볼 시장 주식 타입
TransCode Therapeutics Inc RNAZ 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.056 10.18% 0.6059 03:33:30
개장가 저가 고가 종가 전일 종가
0.5489 0.53 0.629 0.5499
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
15/04/202422:00GLOBETransCode Therapeutics Announces FDA Clearance To Initiate..
03/04/202422:10GLOBETransCode Therapeutics Reports 2023 Results; Provides..
28/03/202421:30GLOBETransCode Therapeutics Announces Appointment of Daniel..
11/03/202422:00GLOBETransCode Therapeutics and Akribion Genomics Report Progress..
07/03/202406:15GLOBETransCode Therapeutics To Present At 2024 RNA Leaders Europe..
20/02/202422:00GLOBETransCode Therapeutics Reports Publication of United States..
16/02/202406:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202410:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/02/202406:33EDGAR2Form 8-K - Current report
01/02/202406:05GLOBENasdaq Determines TransCode Therapeutics Compliance with..
29/01/202422:30GLOBETransCode Therapeutics and Debiopharm Announce Collaboration..
23/01/202406:45EDGAR2Form 8-K - Current report
23/01/202406:45GLOBETransCode Therapeutics Announces Closing of $7.25 Million..
20/01/202411:57EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
19/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
19/01/202403:27GLOBETransCode Therapeutics Announces Pricing of $7.25 Million..
19/01/202400:39EDGAR2Form S-1/A - General form for registration of securities..
17/01/202421:06EDGAR2Form S-1/A - General form for registration of securities..
17/01/202406:01EDGAR2Form 8-K - Current report
13/01/202406:05GLOBETransCode Therapeutics Reports Further Restructuring to..
11/01/202422:22EDGAR2Form S-1 - General form for registration of securities under..
11/01/202422:00GLOBETransCode Therapeutics Announces 1-for-40 Reverse Stock..
09/01/202406:01EDGAR2Form 8-K - Current report
05/01/202402:41EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
04/01/202422:05GLOBETransCode Therapeutics Publishes Open Letter Outlining..
19/12/202306:28EDGAR2Form DEF 14A - Other definitive proxy statements
12/12/202322:30GLOBETransCode Therapeutics Reports Positive Pre-Clinical Results..
09/12/202306:57EDGAR2Form PRE 14A - Other preliminary proxy statements
09/12/202306:56EDGAR2Form 8-K - Current report
08/12/202306:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/12/202323:00GLOBETransCode Therapeutics To Present Phase 0 Data at 2023 San..
05/12/202307:07EDGAR2Form 8-K - Current report
05/12/202306:10GLOBETransCode Therapeutics Announces Closing of $1.2 Million..
02/12/202307:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/12/202304:53GLOBETransCode Therapeutics Announces $1.2 Million Registered..
15/11/202306:40EDGAR2Form 8-K - Current report
15/11/202306:30GLOBETransCode Therapeutics Reports Third Quarter 2023 Results;..
10/11/202306:13EDGAR2Form 8-K - Current report
01/11/202311:20APSBiotech Shares Bid Up Following Public Offering Cancellation
31/10/202305:33GLOBETransCode Therapeutics Withdraws Public Offering
28/10/202305:06EDGAR2Form 8-K - Current report
27/10/202321:00GLOBENasdaq Panel Grants TransCode Therapeutics Extension for..
27/10/202305:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/10/202305:19GLOBETransCode Therapeutics Announces Public Offering of Common..
26/10/202321:00GLOBETransCode Therapeutics Announces Prolonged Survival in..
24/10/202321:05EDGAR2Form 8-K - Current report
24/10/202321:00GLOBETransCode Therapeutics Announces Preliminary Clinical..
16/10/202321:00GLOBETransCode Therapeutics Reports Successful Treatment of..
11/10/202305:00EDGAR2Form SC 13D/A - General statement of acquisition of..
03/10/202305:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
RNAZ
TransCode Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유